Skip to content
PICO Portalanswers from OpenAlex

CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy

PaperCitations, authors & open-access status

CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy is a paper indexed in PICO Portal from OpenAlex.

How many citations does CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy have?

PICO Portalcitation count

CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy has 1,358 citations in the OpenAlex counts PICO Portal stores.

When was CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy published?

PICO Portalyear

CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy has 2017 year in the PICO Portal index.

What is the open-access status of CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy?

PICO Portaloa status

CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy has closed oa status in the PICO Portal index.

What is the DOI of CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy?

PICO Portaldoi

The DOI for CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy is on the source record.

What is the PMID of CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy?

PICO Portalpmid

The PMID for CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy is on the source record.

What is the OpenAlex record for CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy?

PICO Portalopenalex

The OpenAlex for CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial